Targeting Lung Cancer Stem Cells: Research and Clinical Impacts

Zakaria, Norashikin and Satar, Nazilah Abdul and Halim, Noor Hanis Abu and Ngalim, Siti Hawa and Yusoff, Narazah Mohd and Lin, Juntang and Yahaya, Badrul Hisham (2017) Targeting Lung Cancer Stem Cells: Research and Clinical Impacts. Frontiers in Oncology, 7 (80). pp. 1-10. ISSN 2234-943X

Download (429kB) | Preview


Lung cancer is the most common cancer worldwide, accounting for 1.8 million new cases and 1.6 million deaths in 2012. Non-small cell lung cancer (NSCLC), which is one of two types of lung cancer, accounts for 85–90% of all lung cancers. Despite advances in therapy, lung cancer still remains a leading cause of death. Cancer relapse and dissemination after treatment indicates the existence of a niche of cancer cells that are not fully eradicated by current therapies. These chemoresistant populations of cancer cells are called cancer stem cells (CSCs) because they possess the self-renewal and differentiation capabilities similar to those of normal stem cells. Targeting the niche of CSCs in combination with chemotherapy might provide a promising strategy to eradicate these cells. Thus, understanding the characteristics of CSCs has become a focus of studies of NSCLC therapies.

Item Type: Article
Subjects: R Medicine > RK Dentistry > RK1-715 Dentistry
Divisions: Institut Perubatan & Pergigian Termaju (Advanced Medical & Dental Institute (AMDI)) > Article
Depositing User: Mr Noorazilan Noordin
Date Deposited: 26 Oct 2017 04:42
Last Modified: 12 Feb 2018 08:09

Actions (login required)

View Item View Item